Skip to content

Evaluation of Laparoscopic Internal Retractor Device

Evaluation of the Efficacy and Safety of the Endograb: A Laparoscopic Internal Retractor Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00711581
Enrollment
10
Registered
2008-07-09
Start date
2008-08-31
Completion date
2011-08-31
Last updated
2014-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholelithiasis

Keywords

Cholecystectomy, Cholecystectomy, Laparoscopic, Laparoscopy

Brief summary

The purpose of this study is to determine the safety and efficacy of the Endograb system which is an internal laparoscopic retractor device. This retractor device is inserted into the abdominal cavity through one of the 5 mm trocars and obviates the need for a separate dedicated trocar for retraction. Therefore enables the reduction of the number of abdominal incisions in a laparoscopic operation.

Interventions

DEVICEGallbladder retraction

The gallbladder will be retracted using the Endograb retractor

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Symptomatic cholelithiasis * Age 18-60 * ASA 1-2 * Able to sign an informed consent

Exclusion criteria

* ASA 3 or more * Acute cholecystitis * Choledocholithiasis * Coagulation disorders * Patients on blood thinners * Use of Steroids

Design outcomes

Primary

MeasureTime frame
Outcome will be either success or failure. Success if the organ will be retracted adequately with the Endograb retractor. Failure if it will be necessary to add another trocar for inserting a retracting instrument.1 year

Secondary

MeasureTime frame
No adverse effects related directly to the use of the Endograb retractor.1 year

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026